|
Market Closed -
Nasdaq
16:00:00 2026-10-22 EDT
|
5-day change | 1st Jan Change | ||
| 4.220 USD | +2.68% |
|
+40.67% | -23.27% |
| 10-16 | Adial Pharmaceuticals, Inc. Announces Appointment of David Rubenstein, M.D., Ph.D. as Chief Scientist | CI |
| 09-18 | Adial Pharmaceuticals Announces Board Appointments | CI |
| Market Cap | 11.08M 9.88M 9.09M 8.27M 15.52M 1.05B 15.79M 110M 43.2M 551M 41.57M 40.7M 1.73B | P/E 2026 * |
-2.79x | P/E 2027 * | -6.92x |
|---|---|---|---|---|---|
| Enterprise Value | 11.08M 9.88M 9.09M 8.27M 15.52M 1.05B 15.79M 110M 43.2M 551M 41.57M 40.7M 1.73B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
92.92% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ADIL | Delayed | |
CBOE
| ADIL | Real-time |
Last Transcript: Adial Pharmaceuticals, Inc.
| 23-03-07 | Wall Street kleurt rood door Powell | |
| 23-03-07 | Havikige Powell duwt Wall Street in het rood | |
| 23-03-07 | Wall Street wacht op Powell |
| 1 day | +2.68% | ||
| 1 week | +40.67% | ||
| Current month | +5.24% | ||
| 1 month | -4.09% | ||
| 3 months | +54.01% | ||
| 6 months | +165.41% | ||
| Current year | -23.27% |
| 1 week | 3.07 |  | 4.41 |
| 1 month | 3 | | 4.66 |
| Current year | 1.31 | | 7.2 |
| 1 year | 1.31 | | 9.52 |
| 3 years | 1.31 | | 104.25 |
| 5 years | 1.31 | | 2,387.5 |
| 10 years | 1.31 | | 5,900 |
| Manager | Title | Age | Since |
|---|---|---|---|
Cary Claiborne
CEO | Chief Executive Officer | 65 | 2022-08-17 |
Vinay Shah
DFI | Director of Finance/CFO | 63 | 2024-11-15 |
David Rubenstein
CTO | Chief Tech/Sci/R&D Officer | - | 2026-10-15 |
| Director | Title | Age | Since |
|---|---|---|---|
J. Anderson
BRD | Director/Board Member | 76 | 2015-01-31 |
| Director/Board Member | 46 | 2014-08-31 | |
Kevin Schuyler
CHM | Chairman | 57 | 2022-08-17 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/17/26 | Free | Director | 25,666 | 0.9774% | ||
| 4/7/26 | Free | Chief Financial Officer | 17,325 | 1.2133% | ||
| 4/7/26 | Free | Chairman | 9,185 | 0.6432% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.68% | +40.67% | -52.77% | -92.11% | 10.79M | |
| -4.10% | -8.35% | +38.48% | +66.99% | 66.22B | |
| -0.41% | +4.99% | +7.61% | +72.82% | 55.2B | |
| +0.74% | +7.31% | +12.50% | +88.71% | 52.79B | |
| +0.61% | +6.22% | +27.28% | +50.97% | 45.53B | |
| -1.08% | +8.76% | +21.07% | +131.38% | 43.94B | |
| -3.39% | -3.01% | +250.89% | +571.04% | 41.64B | |
| -1.67% | +8.06% | +14.17% | +56.67% | 34B | |
| -8.38% | -9.01% | +25.65% | -1.82% | 25.84B | |
| +1.30% | +6.97% | +38.37% | +28.59% | 23.51B | |
| Average | -1.37% | +6.79% | +38.33% | +97.32% | 38.87B | |
| Weighted average by Cap. | -1.69% | +3.43% | +47.06% | +122.37% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -65.46M -58.34M -53.68M -48.84M -91.66M -6.21B -93.29M -648M -255M -3.25B -246M -240M -10.25B | -21.14M -18.84M -17.33M -15.77M -29.6M -2B -30.12M -209M -82.4M -1.05B -79.3M -77.63M -3.31B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-22 | US$4.220 | +2.68% | 2,269 |
| 26-10-21 | US$4.110 | +7.59% | 21,497 |
| 26-10-20 | US$3.820 | +5.52% | 8,406 |
| 26-10-19 | US$3.620 | +3.72% | 12,077 |
| 26-10-16 | US$3.490 | +11.15% | 56,454 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ADIL Stock
Select your edition
All financial news and data tailored to specific country editions
